Exelixis
EXEL
386 hedge funds and large institutions have $4.42B invested in Exelixis in 2022 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 160 increasing their positions, 125 reducing their positions, and 52 closing their positions.
110% more call options, than puts
Call options by funds: $23.9M | Put options by funds: $11.4M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
28% more repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 125
3% more capital invested
Capital invested by funds: $4.31B → $4.42B (+$111M)
0.74% more ownership
Funds ownership: 86.15% → 86.9% (+0.74%)
4% less funds holding
Funds holding: 400 → 386 (-14)
12% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$89.7M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$16.7M |
| 3 |
Morgan Stanley
New York
|
+$16.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.4M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$15.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$73.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$23.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$22.8M |
| 5 |
Millennium Management
New York
|
-$20.5M |
EXEL Hedge Fund Activity: Q4 2022 in Review
386 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q4 2022, worth a combined $4.42B — up 2.6% from $4.31B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of EXEL and 46 opened new positions — a net loss of 6 holders — while 125 trimmed existing stakes and 160 added.
The largest buyer was Point72 Asset Management, adding an estimated $89.7M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $73.7M sold.
- 386 institutional investors held Exelixis (EXEL) as of Q4 2022, down from 400 in Q3 2022.
- Funds reported $4.42B of Exelixis stock for Q4 2022, up 2.6% quarter-over-quarter.
- 46 funds opened new Exelixis positions in Q4 2022 and 52 closed out, a net change of -6 holders.
- The largest Exelixis buyer in Q4 2022 was Point72 Asset Management, an estimated $89.7M added.
- The largest Exelixis seller in Q4 2022 was T. Rowe Price Investment Management, an estimated $73.7M sold.
Based on aggregated 13F filings for Q4 2022.